Pharmaceutical Intermediates Market Report

Europe Pharmaceutical Intermediates Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 20, 2020
  • PAGES：147
  • REPORT CODE：GMM565952
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Pharmaceutical Intermediates market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Pharmaceutical Intermediates Market Segmentations:

    By Player:

    • Arkema

    • Ganesh Group

    • Dishman Group

    • Midas Pharma

    • Wintersun Chem

    • Codexis

    • Eastar Chem

    • Aceto

    • Lianhe Tech

    • Arlife Sciences

    • BASF

    • Interchem

    • FST Pharma

    • Kangda Chem

    By Type:

    • Industrial Grade

    • Pharmaceutical Grade

    By End-User:

    • Pharmaceutical Company

    • Chemical Production

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Intermediates Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Pharmaceutical Intermediates Market Size and Growth Rate of Industrial Grade from 2014 to 2026

    • 1.3.2 Europe Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Grade from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Company from 2014 to 2026

    • 1.4.2 Europe Pharmaceutical Intermediates Market Size and Growth Rate of Chemical Production from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Pharmaceutical Intermediates Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical Intermediates by Major Types

      • 3.4.1 Market Size and Growth Rate of Industrial Grade

      • 3.4.2 Market Size and Growth Rate of Pharmaceutical Grade

    4 Segmentation of Pharmaceutical Intermediates Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical Intermediates by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical Company for Construction

      • 4.4.2 Market Size and Growth Rate of Chemical Production for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Pharmaceutical Intermediates Production Analysis by Top Regions

    • 5.2 Europe Pharmaceutical Intermediates Consumption Analysis by Top Regions

    • 5.3 Europe Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.3 France Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    6 Product Circulation of Pharmaceutical Intermediates Market among Top Countries

    • 6.1 Top 5 Export Countries in Pharmaceutical Intermediates Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Pharmaceutical Intermediates Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Pharmaceutical Intermediates Landscape Analysis

    • 7.1 Germany Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 7.2 Germany Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    8. UK Pharmaceutical Intermediates Landscape Analysis

    • 8.1 UK Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 8.2 UK Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    9. France Pharmaceutical Intermediates Landscape Analysis

    • 9.1 France Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 9.2 France Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    10. Italy Pharmaceutical Intermediates Landscape Analysis

    • 10.1 Italy Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 10.2 Italy Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    11. Spain Pharmaceutical Intermediates Landscape Analysis

    • 11.1 Spain Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 11.2 Spain Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    12. Poland Pharmaceutical Intermediates Landscape Analysis

    • 12.1 Poland Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 12.2 Poland Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    13. Russia Pharmaceutical Intermediates Landscape Analysis

    • 13.1 Russia Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 13.2 Russia Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    14. Switzerland Pharmaceutical Intermediates Landscape Analysis

    • 14.1 Switzerland Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 14.2 Switzerland Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    15. Turkey Pharmaceutical Intermediates Landscape Analysis

    • 15.1 Turkey Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 15.2 Turkey Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Landscape Analysis by Top Countries

      • 16.3.1 Denmark Pharmaceutical Intermediates Market Volume and Growth Rate

      • 16.3.2 Finland Pharmaceutical Intermediates Market Volume and Growth Rate

      • 16.3.3 Norway Pharmaceutical Intermediates Market Volume and Growth Rate

      • 16.3.4 Sweden Pharmaceutical Intermediates Market Volume and Growth Rate

      • 16.3.6 Iceland Pharmaceutical Intermediates Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Landscape Analysis by Top Countries

      • 17.3.1 Belgium Pharmaceutical Intermediates Market Volume and Growth Rate

      • 17.3.2 Netherlands Pharmaceutical Intermediates Market Volume and Growth Rate

      • 17.3.3 Luxembourg Pharmaceutical Intermediates Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Landscape Analysis by Top Countries

      • 18.3.1 Estonia Pharmaceutical Intermediates Market Volume and Growth Rate

      • 18.3.2 Latvia Pharmaceutical Intermediates Market Volume and Growth Rate

      • 18.3.3 Lithuania Pharmaceutical Intermediates Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Arkema

      • 19.1.1 Arkema Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Ganesh Group

      • 19.2.1 Ganesh Group Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Dishman Group

      • 19.3.1 Dishman Group Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Midas Pharma

      • 19.4.1 Midas Pharma Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Wintersun Chem

      • 19.5.1 Wintersun Chem Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Codexis

      • 19.6.1 Codexis Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Eastar Chem

      • 19.7.1 Eastar Chem Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Aceto

      • 19.8.1 Aceto Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Lianhe Tech

      • 19.9.1 Lianhe Tech Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Arlife Sciences

      • 19.10.1 Arlife Sciences Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 BASF

      • 19.11.1 BASF Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Interchem

      • 19.12.1 Interchem Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 FST Pharma

      • 19.13.1 FST Pharma Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Kangda Chem

      • 19.14.1 Kangda Chem Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    The List of Tables and Figures (Totals 90 Figures and 172 Tables)

    • Figure Product Picture

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Industrial Grade Market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Grade Market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Company from 2014 to 2026

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Chemical Production from 2014 to 2026

    • Figure Germany Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure UK Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure France Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Pharmaceutical Intermediates Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Intermediates Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Pharmaceutical Intermediates

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical Intermediates by Different Types from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediates by Different Types from 2014 to 2026

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Industrial Grade Market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Grade Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Pharmaceutical Intermediates by Different End-Users from 2014 to 2026

    • Table Consumption Share of Pharmaceutical Intermediates by Different End-Users from 2014 to 2026

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Pharmaceutical Company from 2014 to 2026

    • Figure Pharmaceutical Intermediates Market Size and Growth Rate of Chemical Production from 2014 to 2026

    • Table Europe Pharmaceutical Intermediates Production by Major Regions

    • Table Europe Pharmaceutical Intermediates Production Share by Major Regions

    • Figure Europe Pharmaceutical Intermediates Production Share by Major Countries and Regions in 2014

    • Table Europe Pharmaceutical Intermediates Consumption by Major Regions

    • Table Europe Pharmaceutical Intermediates Consumption Share by Major Regions

    • Table Germany Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table UK Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table France Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Italy Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Spain Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Poland Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Russia Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Switzerland Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Turkey Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Pharmaceutical Intermediates Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Germany Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table UK Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table UK Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table France Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table France Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Italy Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Spain Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Poland Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Russia Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Switzerland Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Turkey Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Pharmaceutical Intermediates Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Pharmaceutical Intermediates Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Pharmaceutical Intermediates Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Pharmaceutical Intermediates Market Volume and Growth Rate from 2014 to 2026

    • Table Arkema Profiles

    • Table Arkema Production, Value, Price, Gross Margin 2014-2019

    • Table Arkema Product benchmarking

    • Table Arkema Strategic initiatives

    • Table Arkema SWOT analysis

    • Table Ganesh Group Profiles

    • Table Ganesh Group Production, Value, Price, Gross Margin 2014-2019

    • Table Ganesh Group Product benchmarking

    • Table Ganesh Group Strategic initiatives

    • Table Ganesh Group SWOT analysis

    • Table Dishman Group Profiles

    • Table Dishman Group Production, Value, Price, Gross Margin 2014-2019

    • Table Dishman Group Product benchmarking

    • Table Dishman Group Strategic initiatives

    • Table Dishman Group SWOT analysis

    • Table Midas Pharma Profiles

    • Table Midas Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Midas Pharma Product benchmarking

    • Table Midas Pharma Strategic initiatives

    • Table Midas Pharma SWOT analysis

    • Table Wintersun Chem Profiles

    • Table Wintersun Chem Production, Value, Price, Gross Margin 2014-2019

    • Table Wintersun Chem Product benchmarking

    • Table Wintersun Chem Strategic initiatives

    • Table Wintersun Chem SWOT analysis

    • Table Codexis Profiles

    • Table Codexis Production, Value, Price, Gross Margin 2014-2019

    • Table Codexis Product benchmarking

    • Table Codexis Strategic initiatives

    • Table Codexis SWOT analysis

    • Table Eastar Chem Profiles

    • Table Eastar Chem Production, Value, Price, Gross Margin 2014-2019

    • Table Eastar Chem Product benchmarking

    • Table Eastar Chem Strategic initiatives

    • Table Eastar Chem SWOT analysis

    • Table Aceto Profiles

    • Table Aceto Production, Value, Price, Gross Margin 2014-2019

    • Table Aceto Product benchmarking

    • Table Aceto Strategic initiatives

    • Table Aceto SWOT analysis

    • Table Lianhe Tech Profiles

    • Table Lianhe Tech Production, Value, Price, Gross Margin 2014-2019

    • Table Lianhe Tech Product benchmarking

    • Table Lianhe Tech Strategic initiatives

    • Table Lianhe Tech SWOT analysis

    • Table Arlife Sciences Profiles

    • Table Arlife Sciences Production, Value, Price, Gross Margin 2014-2019

    • Table Arlife Sciences Product benchmarking

    • Table Arlife Sciences Strategic initiatives

    • Table Arlife Sciences SWOT analysis

    • Table BASF Profiles

    • Table BASF Production, Value, Price, Gross Margin 2014-2019

    • Table BASF Product benchmarking

    • Table BASF Strategic initiatives

    • Table BASF SWOT analysis

    • Table Interchem Profiles

    • Table Interchem Production, Value, Price, Gross Margin 2014-2019

    • Table Interchem Product benchmarking

    • Table Interchem Strategic initiatives

    • Table Interchem SWOT analysis

    • Table FST Pharma Profiles

    • Table FST Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table FST Pharma Product benchmarking

    • Table FST Pharma Strategic initiatives

    • Table FST Pharma SWOT analysis

    • Table Kangda Chem Profiles

    • Table Kangda Chem Production, Value, Price, Gross Margin 2014-2019

    • Table Kangda Chem Product benchmarking

    • Table Kangda Chem Strategic initiatives

    • Table Kangda Chem SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US